Literature DB >> 26445141

Neonatal Genetic Variation in Steroid Metabolism and Key Respiratory Function Genes and Perinatal Outcomes in Single and Multiple Courses of Corticosteroids.

K S Borowski1, E A S Clark2, Y Lai3, R J Wapner4, Y Sorokin5, A M Peaceman6, J D Iams7, K J Leveno8, M Harper9, S N Caritis10, M Miodovnik11, B M Mercer12, J M Thorp13, M J O'Sullivan14, S M Ramin15, M W Carpenter16, D J Rouse17, B Sibai18.   

Abstract

OBJECTIVE: The aim of the study is to evaluate the association of steroid metabolism and respiratory gene polymorphisms in neonates exposed to antenatal corticosteroids (ACS) with respiratory outcomes, small for gestational age (SGA), and response to repeat ACS. STUDY
DESIGN: This candidate gene study is a secondary analysis of women enrolled in a randomized controlled trial of single versus weekly courses of ACS. Nineteen single nucleotide polymorphisms (SNPs) in 13 steroid metabolism and respiratory function genes were evaluated. DNA was extracted from placenta or fetal cord serum and analyzed with TaqMan genotyping. Each SNP was evaluated for association via logistic regression with respiratory distress syndrome (RDS), continuous positive airway pressure (CPAP)/ventilator use (CPV), and SGA.
RESULTS: CRHBP, CRH, and CRHR1 minor alleles were associated with an increased risk of SGA. HSD11B1 and SCNN1B minor alleles were associated with an increased likelihood of RDS. Carriage of minor alleles in SerpinA6 was associated with an increased risk of CPV. CRH and CRHR1 minor alleles were associated with a decreased likelihood of CPV.
CONCLUSION: Steroid metabolism and respiratory gene SNPs are associated with respiratory outcomes and SGA in patients exposed to ACS. Risks for respiratory outcomes are affected by minor allele carriage as well as by treatment with multiple ACS. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26445141      PMCID: PMC4860012          DOI: 10.1055/s-0035-1549217

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  24 in total

1.  Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial.

Authors:  Caroline A Crowther; Ross R Haslam; Janet E Hiller; Lex W Doyle; Jeffrey S Robinson
Journal:  Lancet       Date:  2006-06-10       Impact factor: 79.321

2.  Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.

Authors:  Pathik D Wadhwa; Thomas J Garite; Manuel Porto; Laura Glynn; Aleksandra Chicz-DeMet; Christine Dunkel-Schetter; Curt A Sandman
Journal:  Am J Obstet Gynecol       Date:  2004-10       Impact factor: 8.661

3.  Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome.

Authors:  R Haataja; M Rämet; R Marttila; M Hallman
Journal:  Hum Mol Genet       Date:  2000-11-01       Impact factor: 6.150

4.  11Beta-hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites.

Authors:  Mark R Garbrecht; Thomas J Schmidt; Zygmunt S Krozowski; Jeanne M Snyder
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-11-01       Impact factor: 4.310

5.  Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial.

Authors:  D A Guinn; M W Atkinson; L Sullivan; M Lee; S MacGregor; B V Parilla; J Davies; K Hanlon-Lundberg; L Simpson; J Stone; D Wing; K Ogasawara; J Muraskas
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

6.  Targeted disruption of the surfactant protein B gene disrupts surfactant homeostasis, causing respiratory failure in newborn mice.

Authors:  J C Clark; S E Wert; C J Bachurski; M T Stahlman; B R Stripp; T E Weaver; J A Whitsett
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Progressive lung disease and surfactant dysfunction with a deletion in surfactant protein C gene.

Authors:  Aaron Hamvas; Lawrence M Nogee; Frances V White; Pamela Schuler; Brian P Hackett; Charles B Huddleston; Eric N Mendeloff; Fong-Fu Hsu; Susan E Wert; Linda W Gonzales; Michael F Beers; Philip L Ballard
Journal:  Am J Respir Cell Mol Biol       Date:  2003-12-04       Impact factor: 6.914

8.  Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids.

Authors:  Kelan G Tantisira; Stephen Lake; Eric S Silverman; Lyle J Palmer; Ross Lazarus; Edwin K Silverman; Stephen B Liggett; Erwin W Gelfand; Lanny J Rosenwasser; Brent Richter; Elliot Israel; Michael Wechsler; Stacey Gabriel; David Altshuler; Eric Lander; Jeffrey Drazen; Scott T Weiss
Journal:  Hum Mol Genet       Date:  2004-05-05       Impact factor: 6.150

9.  ABCA3 gene mutations in newborns with fatal surfactant deficiency.

Authors:  Sergey Shulenin; Lawrence M Nogee; Tarmo Annilo; Susan E Wert; Jeffrey A Whitsett; Michael Dean
Journal:  N Engl J Med       Date:  2004-03-25       Impact factor: 91.245

10.  Variation in the maternal corticotrophin releasing hormone-binding protein (CRH-BP) gene and birth weight in Blacks, Hispanics and Whites.

Authors:  Pathik D Wadhwa; Hyagriv N Simhan; Sonja Entringer; Claudia Buss; Roger Smith; Calvin J Hobel; Naveed Farhana; Lawrence Shimmin; James E Hixson; Charles F Sing
Journal:  PLoS One       Date:  2012-09-11       Impact factor: 3.240

View more
  3 in total

Review 1.  Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes.

Authors:  Anthony Walters; Christopher McKinlay; Philippa Middleton; Jane E Harding; Caroline A Crowther
Journal:  Cochrane Database Syst Rev       Date:  2022-04-04

Review 2.  Effects of antenatal glucocorticoids on the developing brain.

Authors:  Ross Carson; A Paula Monaghan-Nichols; Donald B DeFranco; Anthony C Rudine
Journal:  Steroids       Date:  2016-06-23       Impact factor: 2.668

3.  Decreased CRHBP expression is predictive of poor prognosis in patients with hepatocellular carcinoma.

Authors:  Hai-Bing Xia; Hui-Ju Wang; Luo-Qin Fu; Shi-Bing Wang; Li Li; Guo-Qing Ru; Xiang-Lei He; Xiang-Min Tong; Xiao-Zhou Mou; Dong-Sheng Huang
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.